Calidi Biotherapeutics, Inc.

First Light Acquisition Group, Inc. (Nasdaq: FLAG) is a special purpose acquisition company that completed its initial public offering in 2021, targeting opportunities in the healthcare and life sciences sector. The SPAC was sponsored by First Light SPAC Management LLC. FLAG filed an 8-K with the SEC on January 9, 2023, under accession number 0001193125-23-004705, in connection with its proposed business combination with Calidi Biotherapeutics, Inc., a clinical-stage oncology company developing cell-based cancer immunotherapies. That de-SPAC transaction subsequently closed in September 2023, with the combined company continuing to trade under a new identity. Sign up at SpacDesk for full filing history, deal terms, and real-time SPAC analytics on FLAG and hundreds of other transactions.